Design Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -9.3% | -9.3% | -9.1% |
| FY2022 | -19.3% | -19.3% | -18.6% |
| FY2023 | -24.1% | -24.1% | -23.1% |
| FY2024 | -20.5% | -20.5% | -19.7% |
| FY2025 | -32.8% | -32.8% | -30.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -9.3% | -9.3% | -9.1% |
| FY2022 | -19.3% | -19.3% | -18.6% |
| FY2023 | -24.1% | -24.1% | -23.1% |
| FY2024 | -20.5% | -20.5% | -19.7% |
| FY2025 | -32.8% | -32.8% | -30.9% |